Cost-effectiveness analysis of disease modifiying drugs (interferons and glatiramer acetate) as first line treatments in remitting-relapsing multiple sclerosis patients

  1. Sánchez-De La Rosa, R.
  2. Sabater, E.
  3. Casado, M.A.
  4. Arroyo, R.
Revista:
Journal of Medical Economics

ISSN: 1369-6998,  1941-837X

Ano de publicación: 2012

Volume: 15

Número: 3

Páxinas: 424-433

Tipo: Artigo

DOI: 10.3111/13696998.2012.654868 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus